The effects of dietary supplementation with Hizikia fusiformis on anti-hyperlipidemic activities were investigated in an animal study in which normal rats were fed Hizikia fusiformis, Hizikia fusiformis ethanol extract and Hizikia fusiformis ethanol extract residue. Serum total lipid and triglyceride levels were significantly (P<0.05) reduced in rats fed Hizikia fusiformis ethanol extract residue at a dose of 200 mg/kg body weight when compared to hyperlipidemic control rats. There were also significant decreases in serum total cholesterol and LDL-cholesterol levels in the rats fed Hizikia fusiformis ethanol extract residue at 200 mg/kg body weight. In addition, the atheroscrelosis index and superoxide dismutase in blood lipids were significantly (P<0.05) lowered in rats fed Hizikia fusiformis ethanol extract residue at 200 mg/kg body weight, as compared to control rats. In conclusion, Hizikia fusiformis and Hizikia fusiformis ethanol extract residue had beneficial antihyperlipidemic and antiarteriosclerosis effects.
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LDL-cholesterol 함량 측정
Low density lipoprotein-cholesterol(LDL-C) Fridewald (Fridewald WT et al., 1972) .
혈중 Lipid peroxide 함량 측정 Yagi (1987) 20 µL 1/12 N H 2 SO 4 4.0 mL 10% phosphotungstic acid 0. 
결과 및 고찰
체중 변화 및 지방 조직의 무게 변동 Table 3 .
hydroxylamine / 3 mM hypoxanthine) 200 µL B(7.5 mU/ml xanthine oxidase(XO) with 0.1 mM EDTA-2Na) 200 µL , 37 water bath 40 .
C(300 of sulfanilic acid / 5.0 mg N-1-naphthyl-ethylenediamine in 500 µL of 16.7% acetic acid) 2.0 mL 20 550 nm superoxide dismutase . superoxide 1.9 0.2 mg/dL 0.4 0.1 mg/dL . , ethanol ethanol 200 mg/kg 1.5 0.1 mg/ dL, 1.7 0.1 mg/dL 1.3 0.1 mg/dL . LDL-, HDL- (Goldstein JL et al., 1975; Ross R, 1986 혈중 hydroxy radical 생성 및 superoxide dismutase(SOD)활성 Unit : on unit of SOD was defined as the which inhibited the reduced of alkaline DMSO-mediated adrechrome by 50% in one mL of blood. 
간장 조직중의 TBARS 농도 변화

